Clinical trial
Efficacy of a Short-term Sequential Therapy Versus Intravenous Standard Treatment for Patients With Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.
NCT01875263 is registered in ClinicalTrials.gov with Fundación Pública Andaluza Progreso y Salud as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy of a Short-term Sequential Therapy Versus Intravenous Standard Treatment for Patients With Non-complicated Catheter Related Bacteremia by Methicillin- Susceptible S.Aureus.
- Lead sponsor
- Fundación Pública Andaluza Progreso y Salud
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- May 31, 2013
- Completion date
- November 30, 2014
- Enrollment
- 1 (actual)
- Sites
- 11
Conditions
As the registry lists them; a condition with its own page is linked.
staphylococcus